16 participants
A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-27
- Start Date:
- 2020-04-30
- Completion:
- 2022-10-31
Conditions
- Waldenstrom's Macroglobulinemia
Interventions
- DRUG
No Results Yet